VBI Vaccines Inc

VBIV
0,5905
0,0005 (0,08%)
Dopo l'orario di negoziazione
Ultimo aggiornamento: 22:14:55
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
16/4/202414:00BWVBI Vaccines Reports Full Year 2023 Financial Results
11/4/202422:05BWVBI Vaccines Announces Closing of $2 Million Registered..
09/4/202420:45BWVBI Vaccines Announces $2 Million Registered Direct Offering..
03/4/202414:00BWVBI Vaccines Presents Encouraging Early Tumor Response Data..
02/4/202414:00BWVBI Vaccines Announces Expanded Strategic Partnership with..
14/2/202414:34EDGAR2Form 8-K - Current report
14/2/202413:00BWVBI Announces Agreement to Sell Manufacturing Capabilities,..
06/2/202422:23EDGAR2Form 8-K - Current report
23/1/202422:15EDGAR2Form 8-K - Current report
11/1/202422:15EDGAR2Form 8-K - Current report
26/12/202322:15EDGAR2Form 8-K - Current report
12/12/202322:15EDGAR2Form 8-K - Current report
29/11/202322:15EDGAR2Form 8-K - Current report
20/11/202314:00EDGAR2Form 8-K - Current report
20/11/202314:00BWVBI Vaccines Presents Additional Biomarker Data from Phase..
14/11/202322:07EDGAR2Form 8-K - Current report
14/11/202322:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/11/202322:05BWVBI Vaccines Reports Third Quarter 2023 Financial Results
03/11/202322:00EDGAR2Form 8-K - Current report
26/10/202314:00EDGAR2Form 8-K - Current report
26/10/202314:00BWVBI Vaccines Expands Proprietary Technology Platforms With..
27/9/202313:30EDGAR2Form 8-K - Current report
27/9/202313:30BWVBI Vaccines’ Pan-Coronavirus Vaccine Candidate, VBI-2901,..
07/9/202314:00EDGAR2Form 8-K - Current report
07/9/202314:00BWVBI Vaccines Announces Dosing of First Patients in Phase 2b..
06/9/202315:12EDGAR2Form 8-K - Current report
06/9/202314:00BWVBI Vaccines Partner Brii Biosciences Announces Topline..
14/8/202314:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202314:00EDGAR2Form 8-K - Current report
14/8/202314:00BWVBI Vaccines Reports Second Quarter 2023 Financial Results
31/7/202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/7/202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/7/202300:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/7/202300:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/7/202300:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/7/202300:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/7/202300:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/7/202300:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/7/202300:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/7/202300:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/7/202300:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/7/202300:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/7/202322:05EDGAR2Form 8-K/A - Current report: [Amend]
24/7/202314:00EDGAR2Form 8-K - Current report
24/7/202314:00BW VBI Vaccines Announces Closing of Underwriters’ Partial..
20/7/202322:16EDGAR2Form SC 13G - Statement of acquisition of beneficial..
19/7/202314:00EDGAR2Form 8-K - Current report
19/7/202314:00BWVBI Vaccines Announces PreHevbri® is Now Available in the..
18/7/202315:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/7/202322:05EDGAR2Form 8-K - Current report
Apertura: 0,585 Min: 0,5611 Max: 0,593
Chiusura: 0,59

La tua Cronologia

Delayed Upgrade Clock

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network